磁共振弹性成像测量肝硬度在代偿性慢性肝病患者中的预后作用
回顾性纳入217例代偿性慢性肝病患者行MRE测肝硬度,平均随访45.0±17.6个月,肝硬度是肝细胞癌发生(HR=1.59/单位)、肝功能失代偿(HR=2.02/单位)和总生存(HR=1.39/单位)的显著预测因素。
要点
- MRE测得的肝硬度值可提供代偿性慢性肝病患者的预后信息。
- 肝硬度值是肝细胞癌发生的显著预测因素。
- 肝硬度值与肝功能失代偿发生和总生存显著相关。
核心结论
- MRE获得的肝硬度是代偿性慢性肝病患者发生肝功能失代偿、肝细胞癌及总生存的显著预测因素。
研究设计与样本
- 回顾性研究,纳入217例接受MRE检查的代偿性慢性肝病患者,平均随访45.0±17.6个月。
诊断标准与关键数值
- 肝细胞癌1、3、5年累积发生率分别为3.8%、14.8%、18.9%。
- 肝功能失代偿1、3、5年累积发生率分别为2.8%、7.3%、11.3%。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To retrospectively evaluate the prognostic role of liver stiffness (LS) measurement using magnetic resonance elastography (MRE) in patients with compensated chronic liver disease (cCLD).
METHODS: We enrolled 217 patients with cCLD who underwent MRE. After mean follow-up of 45.0 ± 17.6 months, cumulative incidence (CI) of hepatocellular carcinoma (HCC) occurrence, development of decompensation and overall survival (OS) were estimated using the Kaplan-Meier method. Prognostic factors were evaluated using the Cox proportional hazard regression model.
RESULTS: During the follow-up period, HCC occurred in 33 patients, and 1-, 3- and 5-year CIs of HCC occurrence were 3.8%, 14.8% and 18.9%, respectively. The LS value was a significant predictive factor for HCC occurrence [p < 0.001, hazard ratio (HR) = 1.59 per unit (1.25-2.03)]. Eighteen patients experienced hepatic decompensation, and 1-, 3- and 5-year CIs of decompensation were 2.8%, 7.3% and 11.3%, respectively. The LS value was also significantly associated with decompensation development [p < 0.001, HR = 2.02 per unit (1.37-2.98)]. Fourteen patients died, and 1-, 3- and 5-year OSs were 99.1%, 98.0% and 89.8%, respectively. The LS value was demonstrated to be a significant affecting factor for OS [p = 0.008, HR = 1.39 per unit (1.10-1.78)].
CONCLUSIONS: LS obtained from MRE was a significant predictive factor for the development of decompensation, HCC occurrence and OS in cCLD patients.
KEY POINTS: • Liver stiffness (LS) values obtained from MRE can provide prognostic information. • The LS value was a significant predictive factor for occurrence of hepatocellular carcinoma. • The LS value was significantly associated with development of hepatic decompensation. • Survival of compensated chronic liver disease patients was affected by the LS value.
引用
- Lee DH, Lee JM, Chang W, et al. Prognostic Role of Liver Stiffness Measurements Using Magnetic Resonance Elastography in Patients with Compensated Chronic Liver Disease. Eur Radiol. 2018. PMID: 29488082. doi:10.1007/s00330-017-5278-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。